Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

Página do item simplificado
dc.citation.issue2
dc.citation.volumev. 12
dc.contributor.authorAdams, Paul
dc.contributor.authorAltes, Albert
dc.contributor.authorBrissot, Pierre
dc.contributor.authorButzeck, Barbara
dc.contributor.authorCabantchik, Ioav
dc.contributor.authorCancado, Rodolfo
dc.contributor.authorDistante, Sonia
dc.contributor.authorEvans, Patricia
dc.contributor.authorEvans, Robert
dc.contributor.authorGanz, Tomas
dc.contributor.authorGirelli, Domenico
dc.contributor.authorHultcrantz, Rolf
dc.contributor.authorMcLaren, Gordon
dc.contributor.authorMarris, Ben
dc.contributor.authorMilman, Nils
dc.contributor.authorNemeth, Elizabeta
dc.contributor.authorNielsen, Peter
dc.contributor.authorPineau, Brigitte
dc.contributor.authorPiperno, Alberto
dc.contributor.authorPorto, Graca
dc.contributor.authorPrince, Dianne
dc.contributor.authorRyan, John
dc.contributor.authorSanchez, Mayka
dc.contributor.authorSantos, Paulo [UNIFESP]
dc.contributor.authorSwinkels, Dorine
dc.contributor.authorTeixeira, Emerencia
dc.contributor.authorToska, Ketil
dc.contributor.authorVanclooster, Annick
dc.contributor.authorWhite, Desley
dc.coverageNew York
dc.date.accessioned2020-07-20T16:31:18Z
dc.date.available2020-07-20T16:31:18Z
dc.date.issued2018
dc.description.abstractAlthough guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p. Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.en
dc.description.affiliationWestern Univ, Univ Hosp, London, ON, Canada
dc.description.affiliationAsociac Espanola Hemocromatosis, Santa Coloma, Spain
dc.description.affiliationUniv Hosp Pontchaillou, INSERM, Unit 1241, Rennes, France
dc.description.affiliationHaemochromatosis Int, London, England
dc.description.affiliationEuropean Federat Assoc Patients Haemochromatosis, Seine, France
dc.description.affiliationHaemochromatose Vereinigung Deutschland, Hurth, Germany
dc.description.affiliationInt Bioiron Soc, Schaumburg, IL USA
dc.description.affiliationHebrew Univ Jerusalem, Jerusalem, Israel
dc.description.affiliationSanta Casa Med Sch Sao Paulo, Div Hematol, Sao Paulo, SP, Brazil
dc.description.affiliationOslo Univ Hosp, Dept Med Biochem, Oslo, Norway
dc.description.affiliationBrunel Univ, Sch Engn & Design, Dept Elect & Comp Engn, Uxbridge, Middx, England
dc.description.affiliationHaemochromatosis Soc, Barnet, Herts, England
dc.description.affiliationUniv Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
dc.description.affiliationUniv Verona, Dept Med, Veneto Reg Referral Ctr Iron Metab Disorders, Verona, Italy
dc.description.affiliationKarolinska Inst, Dept Med, Unit Gastroenterol & Rheumatol, Stockholm, Sweden
dc.description.affiliationUniv Calif Irvine, Div Hematol Oncol, Irvine, CA USA
dc.description.affiliationHaemochromatosis Australia, Meridan Plains, Australia
dc.description.affiliationDanish Haemochromatosis Assoc, Copenhagen, Denmark
dc.description.affiliationUniv Calif Los Angeles, David Geffen Sch Med, Ctr Iron Disorders, Los Angeles, CA 90095 USA
dc.description.affiliationUniv Med Ctr Hamburg, Inst Biochem & Mol Zellbiol, Hamburg, Germany
dc.description.affiliationFederat Francaise Assoc Malad Hemochromatose, Paris, France
dc.description.affiliationUniv Milano Bicocca, Dept Med & Surg, Ctr Rare Dis, Monza, Italy
dc.description.affiliationAssoc Study Hemochromatosis & Iron Overload Dis, Monza, Italy
dc.description.affiliationUniv Porto, Inst Biol Mol & Celular, Porto, Portugal
dc.description.affiliationOxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford, England
dc.description.affiliationUniv Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Heart Inst InCor, Lab Genet & Mol Cardiol, Sch Med, 03 Maio St INFAR,4 Andar, Sao Paulo, SP, Brazil
dc.description.affiliationRadboudumc, Dept Lab Med, Nijmegen, Netherlands
dc.description.affiliationUniv Porto, Inst Invest & Inovacao Saude, Porto, Portugal
dc.description.affiliationNorwegian Haemochromatosis Assoc, Bergen, Norway
dc.description.affiliationUniv Hosp Leuven, Louvain, Belgium
dc.description.affiliationUniv Plymouth, Plymouth, Devon, England
dc.description.affiliationHosp Santo Antonio, Ctr Hosp Porto, Porto, Portugal
dc.description.affiliationUniv Porto, Fac Ciencias, Porto, Portugal
dc.description.affiliationAssoc Portuguesa Hemocromatose, Porto, Portugal
dc.description.affiliationHaemochromatose Vereniging Vlaanderen, Leuven, Belgium
dc.description.affiliationUnifespUniv Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil
dc.description.sourceWeb of Science
dc.description.sponsorshipLa Jolla
dc.description.sponsorshipNovartis
dc.format.extent83-86
dc.identifierhttp://dx.doi.org/10.1007/s12072-018-9855-0
dc.identifier.citationHepatology International. New York, v. 12, n. 2, p. 83-86, 2018.
dc.identifier.doi10.1007/s12072-018-9855-0
dc.identifier.fileWOS000430317500001.pdf
dc.identifier.issn1936-0533
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/55867
dc.identifier.wosWOS:000430317500001
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofHepatology International
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleTherapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotypeen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
WOS000430317500001.pdf
Tamanho:
332.53 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
Coleções
EPM - Artigos